Ljungman, P.

patient platelet transfusion donor study transplantation allogeneic disease autologou reference treatment blood allogeneic hsct autologous hsct group transplant count platelet transfusion lymphoma therapy marrow cell transplantation trial result indication chemotherapy europe p ljungman platelet support increment children platelet transfusions period sibling cycle relapse support conditioning event number posttransfusion randomized component response phase europe fi rst-line therapy fi rst cr score fi rst-line treatment effect high-dose leukemia outcome regimen table platelet dose european group bene fit procedure cancer tumours 24- difference rst-line sample platelet components high-dose chemotherapy high-dose therapy marrow transplantation cycle 1 hla-identical option hodgkin oncol classi hla-identical sibling bone marrow transplantation treatment groups ljungman 109/